<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since 1983 at the Alfred Hospital 4 patients with thrombotic or embolic vertebrobasilar occlusions have been treated with intra-arterial streptokinase (SK) infusions for the effects of persisting <z:e sem="disease" ids="C0521541" disease_type="Disease or Syndrome" abbrv="">brainstem ischaemia</z:e> despite anticoagulation with <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>In 3 cases there was immediate and dramatic neurological improvement, in <z:hpo ids='HP_0000001'>all</z:hpo> cases associated with arteriographically demonstrated reperfusion of a blocked vessel </plain></SENT>
<SENT sid="2" pm="."><plain>Two of these patients suffered further thromboembolic vertebral or basilar <z:mp ids='MP_0006134'>artery occlusions</z:mp> (3 days and 2 years later) but recovered fully without further thrombolytic therapy </plain></SENT>
<SENT sid="3" pm="."><plain>The other patient was given intra-arterial SK 12 days after an apparently completed brainstem <z:hpo ids='HP_0001297'>stroke</z:hpo>: the therapy failed to cause reperfusion of a vertebral occlusion or produce any clinical improvement </plain></SENT>
<SENT sid="4" pm="."><plain>Complications from the therapy were <z:hpo ids='HP_0002018'>nausea</z:hpo> requiring the termination of the SK infusion in one case, easily controlled <z:mp ids='MP_0001914'>bleeding</z:mp> from a recent surgical wound, and a clinically insignificant haemorrhagic transformation of <z:e sem="disease" ids="C0236073" disease_type="Disease or Syndrome" abbrv="">cerebellar infarction</z:e> in a third </plain></SENT>
<SENT sid="5" pm="."><plain>The benefits of thrombolytic therapy in vertebrobasilar <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> and the dose of streptokinase required are discussed </plain></SENT>
</text></document>